Treace Medical Concepts, Inc. (TMCI) Tops Q2 EPS by 6c

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q2 EPS of ($0.24), $0.06 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $45.4 million versus the consensus estimate of $43.94 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
• SuperCom (SPCB) Tops Q3 EPS by 43c
• BMO Capital Reiterates Outperform Rating on Bunge (BG)